As patients requiring insulin therapy often have clinical features that are also associated with increased fracture risk (such as microvascular complications and longer T2DM duration), it remains unclear whether insulin itself is associated with fracture risk or whether it is a surrogate marker for the severity of T2DM and its associated complications [9]. Here, INS is linked to type 2 diabetes mellitus.